Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK - Dutch biotechnology company Crucell NV said Tuesday it will move production of its anti-diarrhea drug Dukoral out of Sweden in order to save money.
| CRXL | 0 |  -20.5 |
The Leiden-based company said it will end Swedish bulk production of Dukoral in 2012 and move production to other company-owned facilities in Switzerland. It will stop formulation, filling and packaging of Dukoral after 2011, and move those operations to Spain.
Dukoral is an oral vaccine designed to prevent diarrhea caused by cholera, an intestinal infection, along with traveler's diarrhea. The vaccine contains several strains of inactive cholera, along with recombinant cholera toxin B, or rCTB. Production of rCTB will also be moved to Spain from Sweden.
Research activities will be closed by the end of 2008 and moved to Leiden. Nordic sales, distribution and customer service will still be based in Solna, Sweden.
In morning trading, American Depositary Shares of Crucell rose 8 cents to $16.33.
You've heard the talk of "Green" throughout the whole of 2008, bu...
Lenovo, with its IdeaPad line series is previewing Y-Series IdeaPad Y650 laptops at CES in Las Vegas together with other new Ideapad Y-series.
NBC on Thursday announced the 16-member cast of "Celebrity Apprentice.”
AdMob, the world's largest and fastest growing mobile advertising marketplace, today la...
Building your business and corporate credit for your small business.
Buy Real Estate, Tax Liens, and more- Fund your business or franchise without debt
Get your next web design project done with our los angeles web design team - Best web design with great price.
Partners   
|
© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
